Stay updated on ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a new ClinicalTrials.gov release/revision number (v3.5.3 instead of v3.5.2).
    Difference
    0.0%
    Check dated 2026-04-25T18:51:56.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be an internal version update with no visible changes to content or layout.
    Difference
    0.0%
    Check dated 2026-04-18T13:43:15.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-21T01:03:55.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 with no visible changes to study details or trial information.
    Difference
    0.0%
    Check dated 2026-03-06T18:07:10.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Results posting information was added (Results First Posted 2026-02-17; Results First Submitted 2024-03-25), and the study now includes Exploratory Arm 1 and 2 as well as Arm B (RP2D) with related dosing details.
    Difference
    6%
    Check dated 2026-02-20T09:44:24.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T03:43:02.000Z thumbnail image

Stay in the know with updates to ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.